Filing Flows › Pure Bioscience (PURE) › How it makes money
How Pure Bioscience (PURE) makes money
Pure Bioscience (PURE) made $660K of revenue in the fourth quarter fiscal 2026 (Q4 FY26). Product brought in $659K (100%); Royalty brought in $1K (0%).
Drawing the Sankey…
Revenue by segment, Q4 FY26
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Product | $659K | 99.8% | — | — |
| ↳ PURE Hard Surface | $631K | 95.6% | — | — |
| ↳ SILVERION | $28K | 4.2% | — | — |
| Royalty | $1K | 0.2% | — | — |
Where each dollar of revenue goes
| Line | Q4 FY26 | % of revenue |
|---|---|---|
| Revenue | $660K | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q4 FY26 | $659K | -14% |
| Q3 FY26 | $506K | +4% |
| Q2 FY26 | $443K | +13% |
| Q1 FY26 | $707K | +27% |
| Q4 FY25 | $763K | +62% |
| Q3 FY25 | $489K | +11% |
| Q2 FY25 | $391K | +20% |
From Pure Bioscience's 10-K filed Oct 29, 2026 (on EDGAR).
Questions
How does Pure Bioscience make money?
Pure Bioscience (PURE) made $660K of revenue in the fourth quarter fiscal 2026 (Q4 FY26). Product brought in $659K (100%); Royalty brought in $1K (0%).
What is Pure Bioscience's biggest business?
Product: $659K in the fourth quarter fiscal 2026, 100% of revenue.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.